NASDAQ:STAB

Statera Biopharma Stock Insider Trading

Healthcare > Biotechnology

Buy STAB

*Your capital is at risk

$0.0001

+0 (+0%)

At Close: Jun 03, 2026

Statera Biopharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 2.02M and sold 0 STAB shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	0
● Buy	2.02M shares
● Sell	0 shares
100% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 22, 2022 Buy	Common Stock J-Other	Chandrasekhar Satishchandran	Director	0 Value: $0
Feb 22, 2022 Buy	Common Stock J-Other	Chandrasekhar Satishchandran	Director	0 Value: $0
Sep 28, 2021 Buy	Common Stock, par value $0.005 per share A-Award	Markvicka Taunia Chief Operating Officer	C-Suite Officer	100 000 Value: $0
Sep 28, 2021 Buy	Common Stock, par value $0.005 per share A-Award	Markvicka Taunia Chief Operating Officer	C-Suite Officer	100 000 Value: $0
Sep 09, 2021 Buy	Common Stock, par value $0.005 per share A-Award	Saluck Randy S. Director	Director	60 000 Value: $0
Sep 09, 2021 Buy	Common Stock, par value $0.005 per share A-Award	Saluck Randy S. Director	Director	60 000 Value: $0
Sep 09, 2021 Buy	Common Stock, par value $0.005 per share A-Award	Barbarick Steve K Director	Director	60 000 Value: $0
Sep 09, 2021 Buy	Common Stock, par value $0.005 per share A-Award	Verny Lea Director	Director	60 000 Value: $0
Sep 09, 2021 Buy	Common Stock, par value $0.005 per share A-Award	Verny Lea Director	Director	60 000 Value: $0
Sep 09, 2021 Buy	Common Stock, par value $0.005 per share A-Award	Barbarick Steve K Director	Director	60 000 Value: $0
Jul 27, 2021 Buy	Common Stock, par value $0.005 per share A-Award	Handley Michael K President And CEO	CEO / President	296 609 Value: $0
Jul 27, 2021 Buy	Common Stock J-Other	Handley Michael K President And CEO	CEO / President	0 Value: $0
Jul 27, 2021 Buy	Common Stock J-Other	Handley Michael K President And CEO	CEO / President	0 Value: $0
Jul 27, 2021 Buy	Common Stock, par value $0.005 per share A-Award	Handley Michael K President And CEO	CEO / President	296 609 Value: $0
Jul 27, 2021 Buy	Common Stock, par value $0.005 per share A-Award	Buckheit Robert Chief Technology Officer	Officer	24 378 Value: $0
Jul 27, 2021 Buy	Common Stock, par value $0.005 per share A-Award	Selsky Clifford Chief Medical Officer	Officer	101 579 Value: $0
Jul 27, 2021 Buy	Common Stock, par value $0.005 per share A-Award	Mcavoy Cozette M. Chief Legal Officer	Officer	60 947 Value: $0
Jul 27, 2021 Buy	Common Stock, par value $0.005 per share A-Award	Aronstam Peter Chief Financial Officer	C-Suite Officer	141 370 Value: $0
Jul 27, 2021 Buy	Common Stock J-Other	Buckheit Robert Officer	Officer	0 Value: $0
Jul 27, 2021 Buy	Common Stock J-Other	Selsky Clifford Officer	Officer	0 Value: $0
Jul 27, 2021 Buy	Common Stock J-Other	Aronstam Peter Officer	Officer	0 Value: $0
Jul 27, 2021 Buy	Common Stock J-Other	Barbarick Steve K	Director	0 Value: $0
Jul 27, 2021 Buy	Common Stock J-Other	Mcavoy Cozette M. Officer	Officer	0 Value: $0
Jul 27, 2021 Buy	Common Stock J-Other	Markvicka Taunia Chief Operating Officer	C-Suite Officer	0 Value: $0
Jul 27, 2021 Buy	Common Stock J-Other	Markvicka Taunia Chief Operating Officer	C-Suite Officer	0 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT STATERA BIOPHARMA, INC.

Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential imm...

Read Full Profile Here